November is National COPD Awareness Month. This month is meant to bring attention to the disease as it's one of the leading ...

A new study suggests that testing lung function earlier in life could help find people at risk of developing serious lung ...

Use of a COPD care pathway heightened the odds for a pulmonary rehabilitation referral and home discharge in hospitalized ...

Dr. Pajak and Eigenbrode will provide specialized care for patients with pulmonary and respiratory conditions, working ...

The diagnosis? Heart failure with only months to live. However, Eric Borstein fought his way back. With a powerful ...

Men and women with chronic obstructive pulmonary disease (COPD), bronchiectasis, and nontuberculous mycobacterial (NTM) lung ...

Remembering her time as a cheerleader helps columnist Caroline Gainer adjust to the long game of COPD as part of a ...

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are severe pulmonary conditions marked by inflammation ...

Brensocatib, a DPP1 inhibitor, is the first FDA-approved therapy for non-cystic fibrosis bronchiectasis, showing significant clinical and structural benefits. The ASPEN trial demonstrated that ...

Research on Chronic Obstructive Pulmonary Disease (COPD) requires further examination of rural health disparities and the impact of sociocultural and environmental exposures on health outcomes, ...

The American Lung Association Research Institute is investing $22 million to advance research and care for lung disease, ...